$AMBQ

Chen Timothy sold $1.8M of AMBQ (indirect holdings)

Chen Timothy sold 22,414 indirectly-held shares of Ambiq Micro, Inc. (AMBQ) at $78.85 ($1.77M total) on 2026-05-27.

Original reporting
SEC EDGAR · Chen Timothy
Published May 29, 2026, 11:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 11:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBQ
Bearish
medium confidence
Mentioned
$AMBQ
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQBearishLow
01

Why it matters

Traders may briefly reassess sentiment around AMBQ, but there is no accompanying operational or financial update (earnings, guidance, product, or contract) in the article.

02

Market read

A disclosed director sale worth ~$1.77M can influence near-term sentiment/positioning, but it is not a fundamental catalyst by itself.

03

What to watch

The filing notes indirect ownership and does not specify the reason for sale; without a 10b5-1 plan, timing could reflect personal needs rather than conviction.

Relevance 6/10Novelty 6/10Timing: Filed 2026-05-29; sale dated 2026-05-27 (open-market insider sale disclosure).

Background

This is an SEC Form 4 insider transaction disclosure for Ambiq Micro, Inc., reported by a director.

Company-level read

Ticker impact

$AMBQBearishMedium confidence
Context

Ambiq Micro director Timothy Chen sold 22,414 shares in an open-market transaction worth about $1.77M, disclosed via SEC Form 4.

Expected impact

Low, likely limited to short-term sentiment/flow effects rather than a sustained repricing.

Evidence & confidence

The filing provides a disclosed sale price and size, but insider transactions typically have weak causal linkage to near-term earnings or guidance absent accompanying company-specific news.

Market effects

Could marginally affect sentiment toward semiconductor/IoT chip names if traders treat insider selling as a read-through, but no sector-wide catalyst is provided.

No clear regional impact; this is company-specific insider activity.

Limited—no deal, regulation, or macro driver tied to Ambiq’s global demand is mentioned.

Counterpoint

The sale may be routine liquidity/portfolio rebalancing and does not necessarily reflect a negative view on Ambiq’s fundamentals.

Key entities

  • Ambiq Micro, Inc.

    Subject of the insider transaction disclosure; director Timothy Chen sold shares.

  • Chen Timothy

    Director who executed the open-market sale disclosed on SEC Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.